Selected article for: "admission mechanical ventilation and lymphopenia dyspnea"

Author: Caillard, Sophie; Chavarot, Nathalie; Francois, Hélène; Matignon, Marie; Greze, Clarisse; Kamar, Nassim; Gatault, Philippe; Thaunat, Olivier; Legris, Tristan; Frimat, Luc; Westeel, Pierre Francois; Goutaudier, Valentin; Snanoudj, Renaud; Colosio, Charlotte; Sicard, Antoine; Bertrand, Dominique; Mousson, Christiane; Bamoulid, Jamal; Masset, Christophe; Thierry, Antoine; Couzi, Lionel; Chemouny, Jonathan M.; Duveau, Agnes; Moal, Valerie; Blancho, Gilles; Grimbert, Philippe; Durrbach, Antoine; Moulin, Bruno; Anglicheau, Dany; Ruch, Yvon; Kaeuffer, Charlotte; Benotmane, Ilies; Solis, Morgane; Le Meur, Yannick; Hazzan, Marc; Danion, Francois
Title: Is Covid‐19 infection more severe in kidney transplant recipients?
  • Cord-id: e7k4932k
  • Document date: 2020_12_1
  • ID: e7k4932k
    Snippet: There are no studies which have compared the risk of severe Covid‐19 and related mortality between transplant recipients and non‐transplant patients. We enrolled two groups of patients hospitalized for Covid‐19, i.e., kidney transplant recipients from the French Registry of Solid Organ Transplant (n=306) and a single‐center cohort of non‐transplant patients (n=795). An analysis was performed among subgroups matched for age and risk factors for severe Covid‐19 or mortality. Severe Cov
    Document: There are no studies which have compared the risk of severe Covid‐19 and related mortality between transplant recipients and non‐transplant patients. We enrolled two groups of patients hospitalized for Covid‐19, i.e., kidney transplant recipients from the French Registry of Solid Organ Transplant (n=306) and a single‐center cohort of non‐transplant patients (n=795). An analysis was performed among subgroups matched for age and risk factors for severe Covid‐19 or mortality. Severe Covid‐19 was defined as admission (or transfer) to an intensive care unit, need for mechanical ventilation, or death.Transplant recipients were younger and had more comorbidities compared to non‐transplant patients. They presented with higher creatinine levels and developed more episodes of acute kidney injury. After matching, the 30‐day cumulative incidence of severe Covid‐19 did not differ between KTR and non‐transplant patients; however, 30‐day Covid‐19‐related mortality was significantly higher in KTR (17.9% versus 11.4%, respectively, p=0.038). Age >60 years, cardiovascular disease, dyspnea, fever, lymphopenia, and C‐reactive protein (CRP) were associated with severe Covid‐19 in univariate analysis, whereas transplant status and serum creatinine levels were not. Age >60 years, hypertension, cardiovascular disease, diabetes, CRP >60 mg/L, lymphopenia, kidney transplant status (HR=1.55), and creatinine level >115 µmol/L (HR=2.32) were associated with Covid‐19‐related mortality in univariate analysis. In multivariable analysis, cardiovascular disease, dyspnea, and fever were associated with severe disease, whereas age >60 years, cardiovascular disease, dyspnea, fever, and creatinine level>115 µmol/L retained their independent associations with mortality. Kidney transplant recipients had a higher Covid‐19‐related mortality compared to non‐transplant hospitalized patients.

    Search related documents:
    Co phrase search for related documents
    • acute aki kidney injury and admission dyspnea: 1
    • acute aki kidney injury and admission renal function: 1, 2, 3, 4
    • acute aki kidney injury and admission symptom onset: 1, 2
    • acute aki kidney injury and admission symptom onset median time: 1
    • acute aki kidney injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8
    • acute aki kidney injury and low incidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute aki kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • admission creatinine level and low incidence: 1
    • admission dyspnea and lopinavir ritonavir: 1, 2
    • admission dyspnea and low incidence: 1
    • admission dyspnea and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
    • admission pulmonary involvement and lymphocyte count: 1, 2
    • admission symptom onset and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8
    • admission symptom onset median time and lymphocyte count: 1
    • lopinavir ritonavir and low incidence: 1
    • lopinavir ritonavir and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10